PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+10.1%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$248M
AUM Growth
+$248M
(+31%)
Cap. Flow
+$47.9M
Cap. Flow
% of AUM
19.32%
Top 10 Holdings %
Top 10 Hldgs %
32.53%
Holding
95
New
24
Increased
33
Reduced
8
Closed
18
Top Buys
| 1 |
Novartis
NVS
|
$7.27M |
| 2 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$6.67M |
| 3 |
Stryker
SYK
|
$5.16M |
| 4 |
Medpace
MEDP
|
$4.73M |
| 5 |
Abbott
ABT
|
$4.44M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.94M |
| 2 |
Bristol-Myers Squibb
BMY
|
$6.34M |
| 3 |
Universal Health Services
UHS
|
$5.36M |
| 4 |
McKesson
MCK
|
$5.13M |
| 5 |
Owens & Minor
OMI
|
$4.16M |
Sector Composition
| 1 | Healthcare | 82.77% |
| 2 | Financials | 3.23% |
| 3 | Industrials | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$150B
| $9.82M | 2.98% | 84,333 +44,333 | +111% | +$5.16M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $9.12M | 2.77% | 365,000 +165,000 | +83% | +$4.12M |
|
|
3
Abbott
ABT
$231B
| $8.67M | 2.63% | 205,000 +105,000 | +105% | +$4.44M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.13M | 2.47% | 66,375 +21,705 | +49% | +$2.66M |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $8M | 2.43% | 69,333 -8,167 | -11% | -$943K |
|
6
Baxter International
BAX
$12.7B
| $7.62M | 2.31% | 160,000 +12,695 | +9% | +$604K |
|
7
Eli Lilly
LLY
$657B
| $7.49M | 2.28% | 93,375 +37,375 | +67% | +$3M |
|
|
8
Novartis
NVS
$245B
| $7.27M | 2.21% | +92,125 | New | +$7.27M |
|
9
Amgen
AMGN
$155B
| $7.25M | 2.2% | 43,460 +16,210 | +59% | +$2.7M |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $7.25M | 2.2% | 37,391 +7,391 | +25% | +$1.43M |
|
11
Centene
CNC
$14.3B
| $7.13M | 2.17% | 106,479 +1,479 | +1% | +$99K |
|
|
ATHN
12
DELISTED
Athenahealth, Inc.
ATHN
| $6.94M | 2.11% | 55,000 +25,000 | +83% | +$3.15M |
|
|
EVHC
13
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $6.84M | 2.08% | 307,046 +97,046 | +46% | +$2.16M |
|
|
KTWO
14
DELISTED
K2M Group Holdings, Inc
KTWO
| $6.67M | 2.03% | +375,223 | New | +$6.67M |
|
15
GSK
GSK
$79.9B
| $6.49M | 1.97% | 150,357 +51,232 | +52% | +$2.21M |
|
16
Zimmer Biomet
ZBH
$21B
| $5.29M | 1.61% | 40,652 -14,348 | -26% | -$1.87M |
|
|
SIEN
17
DELISTED
Sientra, Inc.
SIEN
| $4.97M | 1.51% | 552,664 +202,664 | +58% | +$1.82M |
|
18
Boston Scientific
BSX
$156B
| $4.76M | 1.45% | 200,000 +15,000 | +8% | +$357K |
|
|
19
Medpace
MEDP
$13.4B
| $4.73M | 1.44% | +158,428 | New | +$4.73M |
|
|
AVXS
20
DELISTED
AveXis, Inc. Common Stock
AVXS
| $4.57M | 1.39% | 111,000 +60,200 | +119% | +$2.48M |
|
|
XENT
21
DELISTED
Intersect ENT, Inc
XENT
| $4.36M | 1.32% | 275,000 +60,000 | +28% | +$950K |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.18M | 1.27% | +61,625 | New | +$4.18M |
|
23
Jazz Pharmaceuticals
JAZZ
$7.75B
| $4.12M | 1.25% | 33,936 +11,936 | +54% | +$1.45M |
|
24
Molina Healthcare
MOH
$9.8B
| $4.08M | 1.24% | +70,000 | New | +$4.08M |
|
25
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.92M | 1.19% | +123,066 | New | +$3.92M |
|